Group One Trading’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.27K | Sell |
147
-100
| -40% | -$1.55K | ﹤0.01% | 1780 |
|
|
2025
Q1 | $3.67K | Sell |
247
-28
| -10% | -$416 | ﹤0.01% | 1597 |
|
|
2024
Q4 | $3.64K | Sell |
275
-7,607
| -97% | -$101K | ﹤0.01% | 1695 |
|
|
2024
Q3 | $112K | Buy |
+7,882
| New | +$112K | ﹤0.01% | 832 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 3039 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 3134 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 3238 |
|
|
2023
Q3 | – | Sell |
-4,975
| Closed | -$78.2K | – | 3257 |
|
|
2023
Q2 | $78.2K | Sell |
4,975
-10,963
| -69% | -$172K | ﹤0.01% | 900 |
|
|
2023
Q1 | $263K | Buy |
+15,938
| New | +$263K | ﹤0.01% | 615 |
|
|
2022
Q4 | – | Sell |
-18,386
| Closed | -$238K | – | 3154 |
|
|
2022
Q3 | $238K | Sell |
18,386
-35,346
| -66% | -$458K | ﹤0.01% | 770 |
|
|
2022
Q2 | $754K | Buy |
53,732
+31,403
| +141% | +$441K | ﹤0.01% | 505 |
|
|
2022
Q1 | $320K | Buy |
+22,329
| New | +$320K | ﹤0.01% | 891 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3223 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3117 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2991 |
|
|
2021
Q1 | – | Sell |
-39,227
| Closed | -$714K | – | 2796 |
|
|
2020
Q4 | $714K | Buy |
+39,227
| New | +$714K | ﹤0.01% | 546 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2409 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2226 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2136 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2120 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2080 |
|
|
2019
Q2 | – | Sell |
-19,202
| Closed | -$391K | – | 2004 |
|
|
2019
Q1 | $391K | Buy |
+19,202
| New | +$391K | ﹤0.01% | 365 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2012 |
|